Given the overall safety profile and increasing availability of medical pregnancy termination drugs, we asked: would the mifepristone–misoprostol regimen for medical termination at ≤10 weeks of gestation meet US Food and Drug Administration regulatory criteria for over-the-counter (OTC) approval, and if not, what are the present research gaps?
Accessing medical and surgical first-trimester abortion services: Women’s experiences and costs from an operations research study in KwaZulu-Natal Province, South Africa
This study explored women’s experiences accessing services and estimate costs incurred for first-trimester abortion at four public hospitals in KwaZulu-Natal Province, South Africa. Despite the availability of government assistance for children through South Africa’s “child grant,” the affordability of raising a child was a major concern for women. Although theoretically available free of charge in the public sector, women experienced challenges accessing abortion services and incurred costs which may have been burdensome given average local earnings. These potential barriers could be addressed by reducing the number of required visits and improving availability of pregnancy tests and supplies in public facilities.
A mixed methods evaluation of the Youth Focused Social Network Initiative for safe abortion in Rupandehi, Nepal
The Youth Focused Social Network Initiative was a program to increase young women’s knowledge of and skills in accessing comprehensive abortion care in Rupandehi, Nepal from 2012-2014. The program trained peer educators to provide information and support related to comprehensive abortion care and encouraged adults to support youth in their communities. This study evaluated the effectiveness of the program and found that it had produced positive results in youth knowledge of and attitudes about comprehensive abortion care. Program expansion should be considered in light of continued need in Nepal.